Fast and compliant: Your FANC licence for clinical trials with radioactive products
Are you planning a clinical trial or clinical investigation in Belgium involving the use of radioactive products (in vivo or in vitro)?
In that case, prior authorisation from the FANC (Federal Agency for Nuclear Control) is required by law, as stipulated in the Royal Decree of 12/07/2015. The success and speed of obtaining the FANC licence for your research depends entirely on the correct and complete composition of the application form. Errors or omissions can lead to time-consuming delays or rejection.
This is where Vinçotte Controlatom's specialised expertise comes in handy. Our recognised experts in medical radiation physics and health physics (radiation protection) support you with the specialised parts of the application, in particular section 4 on medical exposure.
We provide the legally required documentation, including accurate dose estimates and detailed advice for justification and optimisation with regard to imaging, dose exposure and radiation protection, among other things. Our experience with both diagnostic and therapeutic radiopharmaceuticals ensures you receive scientifically sound support.
Minimise the risk of delays and maximise the compliance of your study.
→ Read the full article and contact our experts for efficient guidance.